Company: CRNX
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0001193125-25-175498
Chunk: 1

Company: Crinetics Pharmaceuticals, Inc.
Filing Date: 2025-08-07
Form: 10-Q
Item: Part I, Item 1
Chunk 1
---
 no shares issued or outstanding at June 30, 2025 or December 31, 2024

     —

     —

     Common stock and paid-in capital, $0.001 par; 200,000 shares authorized; 94,126 shares issued and outstanding at June 30, 2025; 92,926 shares issued and outstanding at December 31, 2024

     2,334,538

     2,275,952

     Accumulated other comprehensive income

     1,621

     963

     Accumulated deficit

     (1,164,521
     )

     (952,110
     )

     Stock held in trust

     (112
     )

     —

     Total stockholders’ equity

     1,171,526

     1,324,805

     Total liabilities and stockholders’ equity
      
     $
     1,289,574

     $
     1,434,592

See the accompanying notes to these unaudited condensed consolidated financial statements.